Target intelligence / Profile preview

T-complex protein 1 subunit gamma (CCT3)

Target
CCT3
Molecular classification
Chaperone, Heat shock protein, Chaperonin (TRiC/CCT complex), Other (Protein folding molecular machinery)
01

Overview

**T-complex protein 1 subunit gamma (CCT3)** is a molecular chaperone and a core component of the TRiC/CCT chaperonin complex, which consists of two stacked rings with eight distinct subunits each[1][3][4]. CCT3 assists in the correct folding of a diverse range of client proteins, notably actin and tubulin, via an ATP-dependent mechanism, thereby ensuring protein homeostasis and regulating key cellular functions such as mitosis, apoptosis, and signal transduction[1][2][3][4]. CCT3 and the TRiC/CCT complex play important roles in cell cycle progression and the maintenance of cytoskeletal integrity. CCT3 is frequently upregulated in various cancers, where it facilitates oncogenic signaling (e.g., STAT3 pathway) and serves as a prognostic marker and potential therapeutic target[1][2]. Beyond cancer, CCT3 has roles in neurodevelopment and neurodegeneration, further emphasizing its importance in cellular proteostasis[2][3]. No direct drugs targeting CCT3 are currently listed, but its central role in oncogenic pathways and as a biomarker highlights its potential for future therapeutic targeting[2].

Other names
Chaperonin containing TCP1 subunit 3CCT3CCTGTRIC5TCP-1-gammaCctghTRiC5CCT-gammaNEDSVHPIG48T-complex protein 1 gamma subunitChaperonin containing T-complex polypeptide 1 subunit 3
02

Biological functions

Protein foldingCellular homeostasisCell cycle regulationSignal transductionApoptosis regulationCytoskeletal protein folding (actin, tubulin)Cellular proliferation
03

Disease associations

Cancer (multiple types, including hepatocellular carcinoma, breast cancer, colon cancer, acute myeloid leukemia, ovarian cancer, glioblastoma)Neurodevelopmental disordersNeurodegenerative diseaseOther (biomarker in multiple tumor types)
04

Safety considerations

Essential for protein homeostasis; inhibition may affect cell viability and normal proteome foldingPotential impact on broad cellular processes due to chaperone activity
05

Biomarkers

Cancer diagnosis and prognosis (liver cancer, breast cancer, colon cancer, cholangiocarcinoma, ovarian cancer, glioblastoma, papillary thyroid carcinoma, multiple myeloma, head and neck squamous cell carcinoma, lung adenocarcinoma, cervical cancer)Possible marker for patient selection and survival prediction[2]

Beyond the preview

Go deeper on T-complex protein 1 subunit gamma (CCT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-complex protein 1 subunit gamma (CCT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call